Evaluation of Eribulin Combined with Irinotecan for Treatment of Pediatric Cancer Xenografts

Vincristine combined with camptothecin derivatives showed synergy in preclinical pediatric cancer models, and the combinations are effective in treatment of childhood solid tumors. We determined whether the synergy between vincristine and irinotecan extends to eribulin, another microtubule inhibitor.